TY - JOUR T1 - Cardiovascular disease risk factors in polycystic ovary syndrome. A1 - Dokras,Anuja, PY - 2008/1/9/pubmed PY - 2008/3/28/medline PY - 2008/1/9/entrez SP - 39 EP - 44 JF - Seminars in reproductive medicine JO - Semin Reprod Med VL - 26 IS - 1 N2 - Polycystic ovary syndrome (PCOS) is a common endocrinopathy associated with an increasing number of cardiovascular comorbidities. The relationship between insulin resistance and PCOS was described more than 3 decades ago. Women with PCOS also have an increased prevalence of several established cardiovascular risk factors such as diabetes, hypertension, and dyslipidemia. These factors contribute to the increased risk of endothelial dysfunction, increased carotid artery intima media thickness, and coronary artery calcification noted in women with PCOS compared with controls. Although truncal obesity is very prevalent in PCOS, these surrogate markers of atherosclerosis have been shown to be independent of body weight in young, asymptomatic subjects. Metabolic syndrome is a cluster of risk factors that also confer an increased risk of cardiovascular disease. Women with PCOS have also been shown to have a significantly higher prevalence of metabolic syndrome compared with age-matched controls. Currently, there are no longitudinal studies confirming increased cardiovascular morbidity and/or mortality in women with PCOS. However, the early presence of traditional and other cardiovascular risk factors underscores the need to screen and aggressively counsel and treat these women to prevent future symptomatic cardiovascular disease. SN - 1526-8004 UR - https://www.unboundmedicine.com/medline/citation/18181081/Cardiovascular_disease_risk_factors_in_polycystic_ovary_syndrome_ DB - PRIME DP - Unbound Medicine ER -